Related references
Note: Only part of the references are listed.Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values
O. Karatuna et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Burkholderia pseudomallei
David R. Lonsway et al.
MICROBIAL DRUG RESISTANCE (2020)
Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam
Pham Hong Nhung et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Melioidosis, an emerging infectious disease in the Midwest Brazil A case report
Claudia Elizabeth Volpe-Chaves et al.
MEDICINE (2019)
Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification
Sunisa Chirakul et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Misidentification of Burkholderia pseudomallei and Other Burkholderia Species From Pediatric Infections in Mexico
Georgina Meza-Radilla et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India
Maria Koshy et al.
EMERGING INFECTIOUS DISEASES (2019)
Case Series Study of Melioidosis, Colombia
Jose Y. Rodriguez et al.
EMERGING INFECTIOUS DISEASES (2019)
Melioidosis is in the Americas: A Call to Action for Diagnosing and Treating the Disease
Alfredo G. Torres et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei
Derek S. Sarovich et al.
CLINICAL INFECTIOUS DISEASES (2018)
Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression
Katherine A. Rhodes et al.
MICROBIOLOGY-SGM (2018)
Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance
Sunisa Chirakul et al.
SCIENTIFIC REPORTS (2018)
Melioidosis
W. Joost Wiersinga et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Melioidosis in South America
Dionne B. Rolim et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2018)
Rapid Filter-Based Detection and Culture of Burkholderia pseudomallei from Small Volumes of Urine
Pierre A. Michel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Phylogenetic inference of Coxiella burnetii by 16S rRNA gene sequencing
Heather P. McLaughlin et al.
PLOS ONE (2017)
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method
Samuel Maloney et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2017)
Global and regional dissemination and evolution of Burkholderia pseudomallei
Claire Chewapreecha et al.
NATURE MICROBIOLOGY (2017)
Phylogeography of Burkholderia pseudomallei Isolates, Western Hemisphere
Jay E. Gee et al.
EMERGING INFECTIOUS DISEASES (2017)
Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei
Jessica R. Webb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis
Julia V. Bugrysheva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Antibiotic resistance in Burkholderia species
Katherine A. Rhodes et al.
DRUG RESISTANCE UPDATES (2016)
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
Direk Limmathurotsakul et al.
NATURE MICROBIOLOGY (2016)
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand
Natnaree Saiprom et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Efflux pump-mediated drug resistance in Burkholderia
Nicole L. Podnecky et al.
FRONTIERS IN MICROBIOLOGY (2015)
Finished Annotated Genome Sequence of Burkholderia pseudomallei Strain Bp1651, a Multidrug-Resistant Clinical Isolate
Julia V. Bugrysheva et al.
GENOME ANNOUNCEMENTS (2015)
Complete Genome Sequences for 59 Burkholderia Isolates, Both Pathogenic and Near Neighbor
Shannon L. Johnson et al.
GENOME ANNOUNCEMENTS (2015)
Burkholderia pseudomallei Isolates from Sarawak, Malaysian Borneo, Are Predominantly Susceptible to Aminoglycosides and Macrolides
Yuwana Podin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
D. A. B. Dance et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Pharmacodynamics of Doxycycline and Tetracycline against Staphylococcus pseudintermedius: Proposal of Canine-Specific Breakpoints for Doxycycline
Marit Gaastra Maaland et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Development of Doxycycline MIC and Disk Diffusion Interpretive Breakpoints and Revision of Tetracycline Breakpoints for Streptococcus pneumoniae
Steven D. Dallas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Evolution of Burkholderia pseudomallei in Recurrent Melioidosis
Hillary S. Hayden et al.
PLOS ONE (2012)
Molecular investigations of PenA-mediated beta-lactam resistance in Burkholderia pseudomallei
Drew A. Rholl et al.
FRONTIERS IN MICROBIOLOGY (2011)
The BpeAB-OprB Efflux Pump of Burkholderia pseudomallei 1026b Does Not Play a Role in Quorum Sensing, Virulence Factor Production, or Extrusion of Aminoglycosides but Is a Broad-Spectrum Drug Efflux System
Takehiko Mima et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei
I-Ching Sam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Molecular Basis of Rare Aminoglycoside Susceptibility and Pathogenesis of Burkholderia pseudomallei Clinical Isolates from Thailand
Lily A. Trunck et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis
W Chaowagul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Burkholderia pseudomallei class A β-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition
C Tribuddharat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
